Cellectis Statistics

Total Valuation

Cellectis has a market cap or net worth of EUR 171.16 million. The enterprise value is 109.10 million.

Market Cap	171.16M
Enterprise Value	109.10M

Important Dates

The last earnings date was Sunday, November 3, 2024.

Earnings Date	Nov 3, 2024
Ex-Dividend Date	n/a

Share Statistics

Cellectis has 100.09 million shares outstanding. The number of shares has increased by 57.15% in one year.

Current Share Class	n/a
Shares Outstanding	100.09M
Shares Change (YoY)	+57.15%
Shares Change (QoQ)	+11.40%
Owned by Insiders (%)	1.52%
Owned by Institutions (%)	15.83%
Float	71.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.33
PB Ratio	1.47
P/TBV Ratio	n/a
P/FCF Ratio	3.16
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.44
EV / Sales	3.38
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	2.01

Financial Position

The company has a current ratio of 1.78, with a Debt / Equity ratio of 0.69.

Current Ratio	1.78
Quick Ratio	1.13
Debt / Equity	0.69
Debt / EBITDA	n/a
Debt / FCF	1.49
Interest Coverage	-10.99

Financial Efficiency

Return on equity (ROE) is -82.20% and return on invested capital (ROIC) is -25.71%.

Return on Equity (ROE)	-82.20%
Return on Assets (ROA)	-16.09%
Return on Capital (ROIC)	-25.71%
Revenue Per Employee	147,558
Profits Per Employee	-345,858
Employee Count	221
Asset Turnover	0.12
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.20% in the last 52 weeks. The beta is 3.23, so Cellectis's price volatility has been higher than the market average.

Beta (5Y)	3.23
52-Week Price Change	-33.20%
50-Day Moving Average	1.82
200-Day Moving Average	2.12
Relative Strength Index (RSI)	45.74
Average Volume (20 Days)	39,160

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cellectis had revenue of EUR 32.32 million and -75.74 million in losses. Loss per share was -0.93.

Revenue	32.32M
Gross Profit	31.65M
Operating Income	-69.89M
Pretax Income	-76.20M
Net Income	-75.74M
EBITDA	-60.26M
EBIT	-69.89M
Loss Per Share	-0.93

Full Income Statement

Balance Sheet

The company has 142.64 million in cash and 80.58 million in debt, giving a net cash position of 62.06 million or 0.62 per share.

Cash & Cash Equivalents	142.64M
Total Debt	80.58M
Net Cash	62.06M
Net Cash Per Share	0.62
Equity (Book Value)	116.04M
Book Value Per Share	1.16
Working Capital	115.47M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 56.26 million and capital expenditures -2.07 million, giving a free cash flow of 54.19 million.

Operating Cash Flow	56.26M
Capital Expenditures	-2.07M
Free Cash Flow	54.19M
FCF Per Share	0.54

Full Cash Flow Statement

Margins

Gross margin is 97.96%, with operating and profit margins of -216.28% and -234.39%.

Gross Margin	97.96%
Operating Margin	-216.28%
Pretax Margin	-235.80%
Profit Margin	-234.39%
EBITDA Margin	-186.49%
EBIT Margin	-216.28%
FCF Margin	167.70%

Dividends & Yields

Cellectis does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-57.15%
Shareholder Yield	-57.15%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cellectis has an Altman Z-Score of -1.32. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.32
Piotroski F-Score	n/a